Abstract:Circulation Research, Ahead of Print. BACKGROUND:Hypertrophic cardiomyopathy (HCM) is the most prevalent monogenic heart disorder. However, the pathogenesis of HCM, especially its nongenetic mechanisms, remains largely unclear. TFs (transcription factors) are known to be involved in various biological processes including cell growth. We hypothesized that Sp1 (specificity protein 1), the first purified TF in mammals, plays a role in the cardiomyocyte growth and cardiac hypertrophy of HCM.METHODS:Cardiac-specific conditional knockout of Sp1 mice were constructed to investigate the role of SP1 in the heart. The echocardiography, histochemical experiment, and transmission electron microscope were performed to analyze the cardiac phenotypes of cardiac-specific conditional knockout of Sp1 mice. RNA sequencing, chromatin immunoprecipitation sequencing, and adeno-associated virus experiments in vivo were performed to explore the downstream molecules of SP1. To examine the therapeutic effect of SP1 on HCM, an SP1 overexpression vector was constructed and injected into the mutant allele of Myh6 R404Q/+ (Myh6c. 1211C>T) HCM mice. The human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from a patient with HCM were used to detect the potential therapeutic effects of SP1 in human HCM.RESULTS:The cardiac-specific conditional knockout of Sp1 mice developed a typical HCM phenotype, displaying overt myocardial hypertrophy, interstitial fibrosis, and disordered myofilament. In addition, Sp1 knockdown dramatically increased the cell area of hiPSC-CMs and caused intracellular myofibrillar disorganization, which was similar to the hypertrophic cardiomyocytes of HCM. Mechanistically,Tuft1was identified as the key target gene of SP1. The hypertrophic phenotypes induced by Sp1 knockdown in both hiPSC-CMs and mice could be rescued by TUFT1 (tuftelin 1) overexpression. Furthermore, SP1 overexpression suppressed the development of HCM in the mutant allele of Myh6 R404Q/+ mice and also reversed the hypertrophic phenotype of HCM hiPSC-CMs.CONCLUSIONS:Our study demonstrates that SP1 deficiency leads to HCM. SP1 overexpression exhibits significant therapeutic effects on both HCM mice and HCM hiPSC-CMs, suggesting that SP1 could be a potential intervention target for HCM.

Enhancement of Myocardial Function by Hsp20 is Associated with Decreased Type-1 Phosphatase Activity

Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis.

Cardiac-specific Overexpression of Farnesyl Pyrophosphate Synthase Induces Cardiac Hypertrophy and Dysfunction in Mice.

Hsp20 Functions As A Novel Cardiokine in Promoting Angiogenesis Via Activation of Vegfr2

Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice

Abstract 13694: Hsf1 Attenuates Pressure Overload Induced-cardiac Fibrosis via Inhibiting Smad3 Phosphorylation and Nuclear Translocation

High-Energy Phosphate Metabolism and Creatine Kinase in Failing Hearts - A New Porcine Model

Cardiac Contractile Function Is Enhanced In Isolated Ventricular Myocytes From Growth Hormone Transgenic Mice

Phosphoproteome Analysis of Cardiomyocytes Subjected to Β-Adrenergic Stimulation

Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation

Heat Shock Transcription Factor 1 Regulates Exercise‐induced Myocardial Angiogenesis after Pressure Overload Via HIF‐1α/VEGF Pathway

Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice

Abstract 3: Loss of Type 9 Adenylyl Cyclase Triggers Reduced Phosphorylation of Hsp20 and Diastolic Dysfunction

Mechanistic basis for rescuing hypertrophic cardiomyopathy with myosin regulatory light chain phosphorylation

Overexpression of Heat-Shock Protein 20 in Rat Heart Myogenic Cells Confers Protection Against Simulated Ischemia/Reperfusion Injury

Cardiac Secreted-Hsp90alpha in Cardiomyocyte Hypertrophy by N-Cadherin Mediated Signaling under Pressure Overload

Deficiency of Transcription Factor SP1 Contributes to Hypertrophic Cardiomyopathy

Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy

Heat Shock Transcription Factor 1 Protects Against Pressure Overload-Induced Cardiac Fibrosis Via Smad3

Gene Transfer of Heat-Shock Protein 20 Protects Against Ischemia/reperfusion Injury in Rat Hearts

Role of Heat Shock Transcription Factor 1(Hsf1)-Upregulated Macrophage in Ameliorating Pressure Overload-Induced Heart Failure in Mice